As a kinase inhibitor I would expect it to be about as effective as baricitinib, which means not a whole lot. With leronlimab downregulating JAK1 and JAK2 it's another one that does part of what leronlimab does.
(1)
(0)
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch
benzingaheadline@gmail.com.
Target readers who trust our platform to stay ahead of the curve.
